(Q42409636)

30 October 2017

JAK V617F missense mutation is absent in pancreatic cancer (English)

1 reference

30 October 2017

1 reference

1

1 reference

30 October 2017

Mears L

2

1 reference

30 October 2017

Lea NC

series ordinal

3

1 reference

30 October 2017

Raj K

series ordinal

4

1 reference

30 October 2017

Mufti GJ

series ordinal

5

1 reference

30 October 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

30 October 2017

1 reference

30 October 2017

56

1 reference

30 October 2017

8

1 reference

30 October 2017

1174-1175

1 reference

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

The myeloproliferative disorders

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955495

Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17625156

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17625156

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.2006.117754

1 reference

30 October 2017

1 reference

30 October 2017

PubMed publication ID

17625156

1 reference